3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 38.40
-1.05 (-2.66%)
Mar 4, 2026, 12:00 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 3.07 billion as of March 3, 2026. Its market cap has decreased by -39.59% in one year.
Market Cap
3.07B
Enterprise Value
2.39B
Revenue
324.87M
Ranking
n/a
PE Ratio
23.10
Stock Price
38.40
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 3.07B, an increase of 12.22%. That is a compound annual growth rate of 2.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 3.07B | -18.32% |
| Dec 31, 2025 | 3.76B | -26.72% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ACRO Biomedical | 3.77B |
| BRIM Biotechnology | 3.58B |
| Sagittarius Life Science | 3.49B |
| Shine-On BioMedical | 3.40B |
| SYN-TECH Chem. & Pharm. | 3.23B |
| Syngen Biotech | 3.13B |
| Apex Biotechnology | 2.99B |
| GlycoNex Incorporation | 2.68B |